Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


Expression of a novel factor in human breast cancer cells with metastatic potential.

Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O.

Cancer Res. 1999 Sep 15;59(18):4675-80.


Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.

Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM.

Anticancer Res. 2002 Jul-Aug;22(4):1949-57.


Expression of a novel factor, com1, in early tumor progression of breast cancer.

Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM.

Clin Cancer Res. 2000 May;6(5):1778-83.


HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.

Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. Epub 2001 Jul 31.


Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH.

Cancer Res. 2000 Oct 1;60(19):5578-83.


Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC.

Breast Cancer Res Treat. 2002 Jun;74(3):255-69.


Isolation of a novel gene showing reduced expression in metastatic colorectal carcinoma cell lines and carcinomas.

Fukuda S, Kuroki T, Kohsaki H, Hayashi S, Ozaki K, Yamori T, Tsuruo T, Nakamori S, Imaoka S, Nakamura Y.

Jpn J Cancer Res. 1997 Aug;88(8):725-31.


Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.

Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG.

Cancer Res. 1993 May 1;53(9):2178-87.


Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.

Cancer Res. 2009 Nov 15;69(22):8742-51. doi: 10.1158/0008-5472.CAN-09-1541. Epub 2009 Nov 3.


Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.

McAllister SD, Christian RT, Horowitz MP, Garcia A, Desprez PY.

Mol Cancer Ther. 2007 Nov;6(11):2921-7.


A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD.

Clin Cancer Res. 1999 Sep;5(9):2511-9.


Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.

Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.

Cancer Res. 2007 Sep 15;67(18):8742-51.


[Screening of a sub-clone of human breast cancer cells with high metastasis potential].

Ye LH, Wu LY, Guo W, Ma HT, Zhang XD.

Zhonghua Yi Xue Za Zhi. 2006 Jan 3;86(1):61-5. Chinese.


Development and gene expression profiling of a metastatic variant of the human breast cancer MDA-MB-435 cells.

Bandyopadhyay A, Elkahloun A, Baysa SJ, Wang L, Sun LZ.

Cancer Biol Ther. 2005 Feb;4(2):168-74. Epub 2005 Feb 8.


Supplemental Content

Support Center